BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33201286)

  • 21. Dual-Energy CT-Derived Electron Density for Diagnosing Metastatic Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: Comparison With Conventional CT and FDG PET/CT Findings.
    Nagano H; Takumi K; Nakajo M; Fukukura Y; Kumagae Y; Jinguji M; Tani A; Yoshiura T
    AJR Am J Roentgenol; 2022 Jan; 218(1):66-74. PubMed ID: 34319164
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic Value of
    Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
    Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.
    Pak K; Kim K; Kim MH; Eom JS; Lee MK; Cho JS; Kim YS; Kim BS; Kim SJ; Kim IJ
    PLoS One; 2018; 13(2):e0193403. PubMed ID: 29486012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic Lymph Node Staging by Combined
    Pichler R; De Zordo T; Fritz J; Kroiss A; Aigner F; Heidegger I; Virgolini I; Horninger W; Uprimny C
    Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].
    Shao T; Yu L; Li Y; Chen M
    Zhongguo Fei Ai Za Zhi; 2015 Mar; 18(3):155-60. PubMed ID: 25800571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow.
    Rogasch JMM; Frost N; Bluemel S; Michaels L; Penzkofer T; von Laffert M; Temmesfeld-Wollbrück B; Neudecker J; Rückert JC; Ochsenreither S; Böhmer D; Amthauer H; Furth C
    Lung Cancer; 2021 Jul; 157():66-74. PubMed ID: 33994197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer.
    Alongi F; Ragusa P; Montemaggi P; Bona CM
    Tumori; 2006; 92(4):327-33. PubMed ID: 17036525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Characteristics and Outcome of Pathologic N0 Non-small Cell Lung Cancer Patients With False Positive Mediastinal Lymph Node Metastasis on FDG PET-CT.
    Kim KY; Park HL; Kang HS; Lee HY; Yoo IR; Lee SH; Yeo CD
    In Vivo; 2021; 35(3):1829-1836. PubMed ID: 33910869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
    Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Bogaert J; Maes A; Deneffe GJ; Nackaerts KL; Verschakelen JA; Lerut TE; Mortelmans LA; Demedts MG
    J Clin Oncol; 1998 Jun; 16(6):2142-9. PubMed ID: 9626214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Pilot Study of
    Zhou Y; Gao S; Huang Y; Zheng J; Dong Y; Zhang B; Zhao S; Lu H; Liu Z; Yu J; Yuan S
    Sci Rep; 2017 Jun; 7(1):2877. PubMed ID: 28588317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
    Li X; Zhang H; Xing L; Ma H; Xie P; Zhang L; Xu X; Yue J; Sun X; Hu X; Chen M; Xu W; Chen L; Yu J
    Radiother Oncol; 2012 Feb; 102(2):246-50. PubMed ID: 22100657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
    Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
    Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity.
    Lee JW; Kim BS; Lee DS; Chung JK; Lee MC; Kim S; Kang WJ
    Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1794-802. PubMed ID: 19430783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving diagnostic performance of
    Yang DD; Mirvis E; Goldring J; Patel ARC; Wagner T
    Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
    Vanuytsel LJ; Vansteenkiste JF; Stroobants SG; De Leyn PR; De Wever W; Verbeken EK; Gatti GG; Huyskens DP; Kutcher GJ
    Radiother Oncol; 2000 Jun; 55(3):317-24. PubMed ID: 10869746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Magnetic Resonance Imaging for N-Staging in Patients with Non-Small Cell Lung Cancer. A Systematic Review.
    Brea TP; Raviña AR; Villamor JMC; Gómez AG; de Alegría AM; Valdés L
    Arch Bronconeumol (Engl Ed); 2019 Jan; 55(1):9-16. PubMed ID: 29803524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated analysis of
    Girard A; Rouanne M; Taconet S; Radulescu C; Neuzillet Y; Girma A; Beaufrere A; Lebret T; Le Stanc E; Grellier JF
    Eur Radiol; 2019 Aug; 29(8):4286-4293. PubMed ID: 30666449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.